Introduction and Objectives We wished to examine therelationships between inflammation (FENO),methacholine challenge (AHR) and airway calibre (FEV1%) in a group of mild-to-moderate asthmatics.
Methods We searched our patient database forthose individuals with a known diagnosis of asthma who had a methacholine PC20≤ 8 mg/ml. Data regarding FEV1%, FENO, skinprick and methacholinePC20 were collected and divided into groups based upon AHR: severe (<0.5 mg/ml), moderate (>0.5–2 mg/ml) and mild (>2–8 mg/ml); and FENO: low (<25 ppb), medium (25–50 ppb) and high (>50 ppb).
Results We identified 208 who had a known diagnosis of asthma, a methacholinePC20 ≤8 mg/ml, as well as FENO and skin prick testing. Mean age (SEM) was 41.1 (1). There was an 8.5% difference in FEV1% between groups A and C, (95% CI (2.6% to 14.4%) p=0.002) and a 29% difference for FENO between groups A and C, (95%CI (2% to 48%) p=0.034). There was a 1.29 doubling dilution difference in methacholinePC20 (95%CI (0.26 to 2.33) p= 0.009) between groups D and F. There was no significant difference between FEV1% when grouped by FENO (See Abstract P25 Table 1). Applying multiple stepwise linear regression showed that FENO and FEV1% were both significant predictors of methacholine PC20 (p= 0.002, p<0.001). Only methacholine PC20 was a significant predictor of FENO (p=0.002).
Conclusion Our study has highlighted the disconnect between airway inflammation and airway calibre, whilst showing a significant relationship between AHR versus airway calibre and inflammation. Thus, whilst relationships exist between these independent outcomes, the lack of complete concordance highlights the important role that each contributes to the assessment of the asthmatic individual.
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.